News

Investigators find that ADHD drug MPH impacts the brain differently depending on age.

Poor posture in surgical care has been long associated with worsened clinician health. It is no different in ophthalmology.

Lead investigator of REDUCE-IT trials discusses the impact of trial results and what that means for EPA-based treatments going forward.

In a new trial with 35 healthy women, investigators find that a novel vaccine could effectively and safely treat chlamydia.

Robert G. Gish, MD, and the Global Liver Institute join up for a talk on all things hepatology.

In a new multivariable regression study, investigators link depression with a lack of social support and increased IBD activity.

Use of rivaroxaban (Xarelto) plus aspirin was found to reduce cardiovascular and major limb events in a secondary analysis of the COMPASS trial.

Multiple conditions, especially those common in the elderly, can greatly increase the risk of insomnia.

Considerations for improving upon the diagnosis and management of Alzheimer disease.

A clinical breakdown of what constitutes primary, secondary, chronic, and acute forms of insomnia.

How do the states with the longest-running legislation permitting MAID compare?

Survey responses from 700 Parkinson disease patients and their caregivers show a majority of patients report problems with non-motor symptoms.

A further examination of data from a research clinical database shows the risk of smoking outweigh any potential benefits for UC patients.

OSA patients with certain traits experienced a 73% reduction in AHI events from oral appliance treatment.

The committee meeting, tentatively scheduled for November 14, will have to precede the sNDA PDUFA action date set to review the drug's potential indication for reducing residual cardiovascular risks in patients with elevated triglycerides.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

A recent study examining the effectiveness of an offline, automated smartphone-based AI system could be giving physicians a glimpse into the future of eye screening.

The epicutaneous immunotherapy patch BLA was previously submitted to the FDA last year, but withdrawn due to concerns over manufacturing procedure and quality control.

Early exposure to C. difficile helps infants stave off infection later in life.

Drinking more than 3 servings of caffeinated beverages per day was associated with an increase in migraine headaches.

Investigators in a new cohort study examine social, functional, and medical characteristics for dementia patients living at home, in residential care, and in a nursing home facility.

Individuals with increased levels of inflammation after 1 year were associated higher rates of all-cause mortality and mortality attributable to cardiovascular disease and cancer.

Alkahest announces positive top-line data for phase 2 study to treat mild-to-moderate Alzheimer disease.

Strict adherence to a plant-based diet could result in a 16% reduction in risk of having a cardiovascular disease.

The FDA has been informed by the therapy's manufacturer that data was manipulated during its animal testing phase.

New phase 3 data will evidence an FDA application for the biologic as an add-on therapy for patients aged 6-11 years with AD.

The FDA suggests only limited use of tofacitinib to treat rheumatoid arthritis, ulcerative colitis, or psoriatic arthritis.

A new study found significantly greater COPD development risk among middle-aged women who eat processed meat—and doubly worse risk for those who also smoke and have unhealthy diets.

A 24-week randomized clinical trial found PRT-P led to improvements in social communication skills among children with ASD.

The majority of physicians in a new survey support hiring additional support staff in an effort to alleviate burnout symptoms.